Piper Sandler bullish on DexCom shares citing growth potential and new catalysts
Piper Sandler reaffirmed its Overweight rating on DexCom (NASDAQ:DXCM) stock, maintaining a price target of $90.00. The firm's analysts highlighted several positive developments for the medical device ...
Piper Sandler Remains a Hold on The Hershey Company (HSY)
Piper Sandler analyst Michael Lavery maintained a Hold rating on The Hershey Company (HSY – Research Report) today and set a price target of ...
Piper Sandler Keeps Their Buy Rating on Post Holdings (POST)
In a report released today, Michael Lavery from Piper Sandler maintained a Buy rating on Post Holdings (POST – Research Report), with a price ...